Ten hospitals and health systems posted job listings seeking pharmacy leadership in the last week:
Pharmacy
Four drugs or medical devices approved by the FDA since June 14:
Infusion Options is recalling all lots of unexpired, sterile products that have been distributed to hospitals.
Oncology will continue to be the main research and development focus of the pharmaceutical industry in 2024, according to a new report from Evaluate Pharma.
The Ohio Board of Pharmacy ordered Spring Valley Family Pharmacy in Gallipolis, Ohio, to close "indefinitely" this week, according to The Gallipolis Daily Tribune.
Advertisement
Global pharmaceutical company Sanofi will cut 466 jobs in France and Germany as it works to reorganize its research and development operations, according to EndPoints News.
Amazon is looking to contract with health plans and employers to sell prescription drugs through PillPack, the online pharmacy it acquired last year, STAT reports, citing newly released court documents.
Below are 10 legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last two weeks.
Johnson & Johnson and Roche are forecasted to be the top spenders on research and development in 2024, according to a new report by Evaluate Pharma.
Premier Pharmacy Labs is recalling all its unexpired, sterile drugs after an FDA inspection raised questions about their sterility.